The Stock Exchange and Securities Organization agreed to increase the capital of Jaber Ibn Hayyan Pharmaceutical Company (Dajaber) by 100% from the accumulated profit. The capital increase of 1,134 billion rials of Jaber Ibn Hayyan Pharmaceutical Company from 1,134 billion rials to 2,268 billion rials from the accumulated profit was declared unimpeded by the Stock Exchange Organization. The increase in capital of Jaber Ibn Hayyan Pharmaceutical Company was to compensate for the investments made during the past years and to reform the financial structure, and the live broadcast of the Jaber Pharmaceutical Association in order to increase the capital was successfully held by Roka Assembly System.